2nd patient with stable disease, page-31

@furniture..:-) take heart here.:-)...I read quite a bit and a lot of "experts" out there were saying bios are usually very unpopular sector with investors running scared - decades of lost monies sitting doing nothing and only just depreciating. However, in all the share market history bios had 4 bull runs..and when they happen nothing runs so fast and so hard like biotechs...fortunes are made in a blink of an eye..;-)..they also said bios are due for the next leg up and this decade is shaping to be a biotechs time...my poor understanding of this technology tells me, we are in a right space of cancer fighting compounds - antibodies are hot and they are working...we are not only one of the best technology platforms out there but we are very unique with no competition and good long lasting patents...the way I see it cancer treatments is a very crowded space - so many companies/pharmas are onto it and so much different research is going on...so it is just impossible to pick a winner here..that said I did look a bit into few of the biotechs and nothing excited me as much as PAB..:-) so I jumped right in, buying at market without looking any deeper into their financial figures...lol...we may still go under and never get anywhere or be taken over by a bored guy/institution with deep pockets...that would be a shame...but here is hoping our Management is strong/focused and they will do their best by us and keep us going...I would not mind a good partnership deal with upfront payments and financing of the rest of the trials...said that, after we finish PH2 in current trials we may be asked to do just extension of that and bring our compound straight to market!...need to stay positive here and imagine the best..:-) cheers!..
all in my humble and ignorant blond opinion..:-))dyor...